Authors: Ho, DH Covington, W Brown, N Lin, SN Pazdur, R Huo, YY Creaven, PJ Rustum, YM Meropol, NJ Lassere, Y Kuritani, J Hayakawa, T

Citation: Dh. Ho et al., Oral uracil and Ftorafur plus leucovorin: pharmacokinetics and toxicity inpatients with metastatic cancer, CANC CHEMOT, 46(5), 2000, pp. 351-356

Authors: Baglia, FA Badellino, KO Ho, DH Dasari, VR Walsh, PN

Citation: Fa. Baglia et al., A binding site for the kringle II domain of prothrombin in the Apple 1 domain of factor XI, J BIOL CHEM, 275(41), 2000, pp. 31954-31962

Authors: Ho, DH Badellino, K Baglia, FA Sun, MF Zhao, MM Gailani, D Walsh, PN

Citation: Dh. Ho et al., The role of high molecular weight kininogen and prothrombin as cofactors in the binding of factor XI A3 domain to the platelet surface, J BIOL CHEM, 275(33), 2000, pp. 25139-25145

Authors: Ho, DH Baglia, FA Walsh, PN

Citation: Dh. Ho et al., Factor XI binding to activated platelets is mediated by residues R-250, K-255, F-260 and Q(263) within the apple 3 domain, BIOCHEM, 39(2), 2000, pp. 316-323

Authors: Huynh, DP Del Bigio, MR Ho, DH Pulst, SM

Citation: Dp. Huynh et al., Expression of ataxin-2 in brains from normal individuals and patients withAlzheimer's disease and spinocerebellar ataxia 2, ANN NEUROL, 45(2), 1999, pp. 232-241

Authors: Jacobson, K Rolston, K Elting, L LeBlanc, B Whimbey, E Ho, DH

Citation: K. Jacobson et al., Susceptibility surveillance among gram-negative bacilli at a cancer center, CHEMOTHERA, 45(5), 1999, pp. 325-334